The large part of the industry that makes medicines is this very empirically driven process. Where things really fail is in the clinic, because we never could see the problems until we get to the point where we put these drugs in patients and we say, "Oh no, there's toxicity that we didn't account for." And so the really big opportunity is to have much more of that understanding before you go into patients.
← 12 November 2026No Priors
Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg
Max Jaderberg argues drug discovery stalls because it is empirical trial and error, and that predictive AI models reaching experimental accuracy can move design onto computers, raising success rates and enabling safer, more complex medicines.
Watch on YouTube ↗Word for word
Do more with Charlie
Analyze any YouTube videoPaste a link — get its key points and best quotes in minutes. 10 videos a day.Paste a YouTube link →Your own podcast feedAdd up to 10 YouTube channels you follow. Charlie reads their new episodes for you.Add your channels →
Free — sign in with your email, no password.